Top Markets
Coin of the day
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Rang în acțiuni #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Preț acțiune
$8.46
Ultima sincronizare: 2026-08-28
Capitalizare de piață
$514.33M
Schimbare (1 zi)
-2.08%
Schimbare (1 an)
128.03%
Țară
US
Tranzacționează Kyverna Therapeutics, Inc. (KYTX)

Categorie

Istoricul spliturilor pentru Kyverna Therapeutics, Inc. (KYTX)
Acțiunea Kyverna Therapeutics, Inc. (simbol: KYTX) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Aug 31, 2026.
O acțiune KYTX cumpărată înainte de Aug 31, 2026 este echivalentă astăzi cu 0 acțiuni KYTX.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH